指南与共识胸部技术与安全CT

结缔组织病相关间质性肺病的识别与管理:日本循证共识声明

Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements.
指南 / 共识 · Expert Rev Respir Med · 2023-02-20

该共识基于靶向文献综述制定109条声明,经22名日本多学科专家两轮改良Delphi调查,以0-100分均值≥70为共识阈值,最终93条达成共识。核心推荐包括对CTD患者用HRCT筛查ILD、结合影像、肺功能与血清标志物诊断和评估严重度、定期随访及多学科管理,并转化为临床算法。

要点

  • CTD患者应筛查ILD,通常采用高分辨率CT。
  • 诊断与严重度评估结合影像、肺功能和血清标志物。
  • CTD-ILD需定期随访和多学科管理。

核心结论

  • 通过改良Delphi流程形成93条CTD-ILD管理共识声明并转化为临床算法。

研究设计与样本

  • 基于靶向文献综述制定109条声明,覆盖六个领域。
  • 22名日本肺科、风湿科、病理科和放射科医生参与两轮网络调查。
  • 共识定义为0(强烈反对)至100(强烈同意)量表的均值≥70。

诊断标准与关键数值

  • 共识阈值:0-100量表的均值≥70。
  • 推荐对CTD患者通常采用高分辨率CT筛查ILD。
  • 诊断和严重度评估使用影像、肺功能测试和血清生物标志物。

临床应用与阅片要点

  • 对CTD患者应主动筛查ILD,HRCT是常用筛查工具。
  • 阅片时结合影像、肺功能和血清标志物综合评估诊断与严重度。
  • CTD-ILD患者需定期随访并纳入多学科管理。

局限性

  • 基于文献综述和专家共识而非临床试验证据。
  • 共识仅由日本22名专家形成,外推需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Interstitial lung disease (ILD) is a common complication of connective tissue diseases (CTD), but there are few clinical trials to guide disease management. We aimed to develop expert consensus statements and an algorithm for CTD-ILD management.

RESEARCH DESIGN AND METHODS: Based on a targeted literature review, we developed 109 statements on managing CTD-ILD across six domains. We used a modified Delphi process to survey 22 physicians in Japan involved in managing CTD-ILD (specialists in pulmonology, rheumatology, pathology, and radiology). These panelists participated in two rounds of web-based survey to establish consensus statements, which were used to define an algorithm. Consensus was defined as a mean value ≥70 on a scale of 0 (strong disagreement) to 100 (strong agreement).

RESULTS: Between May-August 2022, consensus was reached on 93 statements on CTD-ILD management. The most important consensus statements included screening CTD patients for ILD (typically with high-resolution computed tomography), using imaging, pulmonary function testing and serum biomarkers for diagnosis and severity assessment, regularly following up patients, and multidisciplinary management of CTD-ILD. Consensus statements were interpreted into an algorithm for clinical guidance.

CONCLUSIONS: Using the Delphi process, we have developed consensus statements and an algorithm to guide clinical decision-making for CTD-ILD.

来源:Expert Rev Respir Med,查看原文。版权归原作者所有。

引用

  1. Kuwana, Bando, Kawahito, et al. Identification and management of connective tissue disease-associated interstitial lung disease: evidence-based Japanese consensus statements. Expert Rev Respir Med. 2023. PMID: 36786105. doi:10.1080/17476348.2023.2176303

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。